Literature DB >> 9565051

The relationship of ocular factors to the incidence and progression of age-related maculopathy.

R Klein1, B E Klein, S C Jensen, K J Cruickshanks.   

Abstract

OBJECTIVE: To examine the association between ocular factors and the incidence and progression of age-related maculopathy. PARTICIPANTS: A population of 3684 adults (43-86 years of age at baseline) living in Beaver Dam, Wis, studied at baseline and 5 years later.
METHODS: Standardized protocols for refraction and determination of iris color, administration of a questionnaire, and slitlamp and retroillumination photographs of the lenses to determine cataract type and stereoscopic color fundus photographs to determine presence and severity of age-related maculopathy. Standard univariate and multivariate analyses were performed. MAIN OUTCOME MEASURES: Incidence and progression of age-related maculopathy.
RESULTS: After controlling for age, eyes that had undergone cataract surgery before baseline were more likely to have progression of age-related maculopathy (odds ratio, 2.71; 95% confidence interval [CI], 1.69-4.35) and to develop signs of late age-related maculopathy (odds ratio, 2.80; 95% CI, 1.03-7.63) than were eyes that were phakic at baseline. These relationships remained after controlling for other risk factors in multivariate analyses. There was no relationship of nuclear cataract, cortical cataract, or iris color to the incidence and progression of age-related maculopathy.
CONCLUSION: These findings indicate a relationship between cataract surgery and increased risk of progression of age-related maculopathy.

Entities:  

Mesh:

Year:  1998        PMID: 9565051     DOI: 10.1001/archopht.116.4.506

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  40 in total

Review 1.  Macular pigment and age related macular degeneration.

Authors:  S Beatty; M Boulton; D Henson; H H Koh; I J Murray
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

2.  Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3.

Authors: 
Journal:  Ophthalmology       Date:  2000-12       Impact factor: 12.079

Review 3.  Epidemiology of age-related maculopathy: a review.

Authors:  Redmer van Leeuwen; Caroline C W Klaver; Johannes R Vingerling; Albert Hofman; Paulus T V M de Jong
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

4.  Measurements of transmission spectrums and estimation of retinal blue-light irradiance values of currently available clear and yellow-tinted intraocular lenses.

Authors:  Masaki Tanito; Tsutomu Okuno; Yoshihisa Ishiba; Akihiro Ohira
Journal:  Jpn J Ophthalmol       Date:  2011-11-19       Impact factor: 2.447

Review 5.  Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges.

Authors:  Jordana K Schmier; Carolyn K Hulme-Lowe
Journal:  Pharmacoeconomics       Date:  2016-03       Impact factor: 4.981

6.  Choroidal neovascularization in highly myopic eyes after cataract surgery.

Authors:  Kengo Hayashi; Kyoko Ohno-Matsui; Soh Futagami; Seiji Ohno; Takashi Tokoro; Manabu Mochizuki
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

7.  The effect of cataract surgery on sleep quality: a systematic review and Meta-analysis.

Authors:  Ling Zheng; Xiao-Hang Wu; Hao-Tian Lin
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

8.  A model of spectral filtering to reduce photochemical damage in age-related macular degeneration.

Authors:  Sanford M Meyers; Mikhail A Ostrovsky; Robert F Bonner
Journal:  Trans Am Ophthalmol Soc       Date:  2004

9.  Risk factors for age related maculopathy in a Japanese population: the Hisayama study.

Authors:  M Miyazaki; H Nakamura; M Kubo; Y Kiyohara; Y Oshima; T Ishibashi; Y Nose
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

10.  Risk factors for age-related maculopathy.

Authors:  Paul P Connell; Pearse A Keane; Evelyn C O'Neill; Rasha W Altaie; Edward Loane; Kumari Neelam; John M Nolan; Stephen Beatty
Journal:  J Ophthalmol       Date:  2009-09-06       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.